Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy Ranjit John, MD, Forum Kamdar, BS, Kenneth Liao, MD, Monica Colvin-Adams, MD, Andrew Boyle, MD, Lyle Joyce, MD The Annals of Thoracic Surgery Volume 86, Issue 4, Pages 1227-1235 (October 2008) DOI: 10.1016/j.athoracsur.2008.06.030 Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 External view of HeartMate II left ventricular assist device. (Illustration © Thoratec Corporation. Reproduced with permission.) The Annals of Thoracic Surgery 2008 86, 1227-1235DOI: (10.1016/j.athoracsur.2008.06.030) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Cross-sectional internal view of HeartMate II left ventricular assist device. (Illustration © Thoratec Corporation. Reproduced with permission.) The Annals of Thoracic Surgery 2008 86, 1227-1235DOI: (10.1016/j.athoracsur.2008.06.030) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Actuarial survival (Kaplan-Meier analysis) of patients undergoing HeartMate II placement as bridge-to-transplant therapy. The Annals of Thoracic Surgery 2008 86, 1227-1235DOI: (10.1016/j.athoracsur.2008.06.030) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions